FindTrial
Sign In

Real world clinical study of Liushen capsule in the treatment of pharyngitis and tonsillitis

Real world clinical study of Liushen capsule in the treatment of pharyngitis and tonsillitis

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2100004400
Enrollment
Unknown
Registered
2021-02-07
Start date
2021-02-15
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pharyngitis, amygdalitis

Interventions

no Liushen capsule group:Nil
Liushen capsule group:Nil

Sponsors

The First Tianjin Medical University General Hospital, Affiliated Hospital of Guangzhou University of traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Experience in respiratory department and ENT Department; 2. According to the diagnosis of acute pharyngitis or acute tonsillitis in the third edition of Otolaryngology Head and neck surgery, patients with pharyngeal red swelling and pain symptoms.

Exclusion criteria

Exclusion criteria: Nil

Design outcomes

Primary

MeasureTime frame
VAS;—

Secondary

MeasureTime frame
Complete antipyretic time;Cure rate of disease;—

Countries

China

Contacts

Public ContactZhou Huifang

General Hospital of Tianjin Medical University

zyyzhf@163.com+86 13821003599

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026